Severe Sepsis Mortality in a Community Teaching. Hospital: 1983–1985 and 1989

Abstract

Despite better understanding of the pathophysiology and hemodynamic abnormalities of severe sepsis, mortality remains high. We examined the severity-adjusted outcome and use of pulmonary artery catheterization (PAC) in patients with severe sepsis during 1983 to 1985 and 1989 to 1990 in an intensive care unit (ICU) staffed by full-time intensivists. A retrospective chart review was conducted on severe sepsis patients admitted to a multidisciplinary ICU of an 850-bed community teaching hospital. Patients were identified at ICU admission and at 24 and 48 hours after ICU admission. Patients were stratified by severity of illness using the Mortality Probability Model (MPM) and presence or absence of a pulmonary artery catheter within the first 48 hours of ICU admission. In the years 1983 through 1985 and 1989 through 1990, respectively, 245 and 132 patients with severe sepsis were identified. The severity-adjusted outcome and use of PAC was analyzed both within and between these two periods. The severity adjusted mortality from sepsis was unchanged over time (63% in 1983–1985 and 51% in 1989–1990; p = 0.491). Pulmonary artery catheter use increased from 52.2% in 1983 to 1985 to 64.4% in 1989 to 1990 (p = 0.023). Invasive monitoring with PAC was used in a less severely ill population; during 1983 to 1985, mean severity estimated by MPM was 0.43 compared with an MPM of 0.32 in 1989 to 1990 (p = 0.003). A significant increase in the therapeutic use of vasoactive drugs (65 vs 81%) to treat severe sepsis was observed over the two periods (p = 0.0005). Outcome of severe sepsis was unchanged during the two periods. Applying an ICU severity-of-illness adjustment model, early employment of pulmonary artery catheters and increased use of vasopressors did not effect outcome in an intensivist-managed ICU. Insertion of pulmonary artery catheters in patients with less severe illness also did not impact outcome. Use of pulmonary artery catheters to monitor and guide treatment needs further rigorous prospective evaluation to define the specific conditions in severely septic patients for which this intervention is most applicable.

Get full access to this article

View all access options for this article.

References

1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864–874

Parker

Fink

MP.

Septic shock. In: Rippe Irwin

Cerra

Fink

, eds. Intensive care medicine, ed 2. Boston: Little, Brown 1991:1886–1900

Parillo

JE.

Septic shock in humans: clinical evaluation, pathogenesis and therapeutic approach. In: Shoemaker

Ayres

Grenvik

, et al, eds. Textbook of critical care, ed 2. Philadelphia, PA: W.B. Saunders, 1989:1006–1024

Parker

Parrillo

JE.

Septic shock and other forms of distributive shock. In: Current therapy in critical care medicine. Philadelphia, PA: B.C. Decker, 1990:44–55

5. Zeigler

Fisher

Sprung

, et al. Treatment of gram negative bacteremia and septic shock with HA1A human monoclonal antibody against endotoxin. A randomized, double blind, placebo-controlled trial. N Engl J Med 1991;324:429–436

6. Greenman

Schein

Martin

, et al. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram negative sepsis. JAMA 1991;266:1097–1102

7. Astiz

Rackow

Falk

, et al. Oxygen delivery and consumption in patients with hyperdynamic septic shock. Crit Care Med 1987;15:26–28

Shoemaker

Appel

PL.

Use of physiologic monitoring to predict outcome and to assist in clinical decisions in critically ill postoperative patients. Am J Surg 1983;146:43–50

Shoemaker

Appel

Kram

HB.

Tissue oxygen debt as a determinant of lethal and nonlethal postoperative organ failure. Crit Care Med 1988;16:1117–1120

10.

10. Tuchschmidt

Fried

Astiz

, et al. Elevation of cardiac output and oxygen delivery improves outcome in septic shock. Chest 1992;102:216–220

11.

11. Shoemaker

Appel

Kram

, et al. Prospective trial of supranormal values of survivors as therapeutic goals in high risk surgical patients. Chest 1988;94:1176–1186

12.

12. Yu

Levy

Smith

, et al. Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients: a prospective, randomized, controlled study. Crit Care Med 1993;21:830–638

13.

Boyd

Grounds

Bennett

ED.

A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients. JAMA 1993;270:2699–2707

14.

14. Ronco

Fenwick

Wiggs

, et al. Oxygen consumption is independent of increases in oxygen delivery by dobutamine in septic patients who have normal or increased plasma lactate. Am Rev Respir Dis 1993;147:23–31

15.

15. Ronco

Renwick

Tweeddale

, et al. Identification of the critical oxygen delivery for anaerobic metabolism in critically ill septic and non-septic humans. JAMA 1993;270:1724–1730

16.

Nelson

LD.

All goals are not the same. Crit Care Med 1993;21:815–817

17.

Dantzker

Foresman

Gutierrez

Oxygen supply and utilization relationships: a re-evaluation. Am Rev Respir Dis 1991;143:675–679

18.

Bone

RC.

Editorial. Abnormal cellular metabolism in sepsis. A new interpretation. JAMA 1992;267:1518–1519

19.

19. Hayes

Timmins

Yau

EHS

, et al. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994;330:1717–1722

20.

Tuchschmidt

Oblitas

Fried

JC.

Oxygen consumption in sepsis and septic shock. Crit Care Med 1991;19:664–671

21.

21. Connors

Sperrof

Dawson

, et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA 1996;276:889–897

22.

Lemeshow

Teres

Avrunin

Gage

RW.

Refining intensive care unit outcome prediction by using changing probabilities of mortality. Crit Care Med 1988;16:470–477

23.

23. Lemeshow

Teres

Klar

, et al. Mortality Probability Models (MPM II) based on an international cohort of intensive care unit patients. JAMA 1993;270:2478–2486

24.

24. SAS Institute Inc. SAS release 6.03. Cary, NC: SAS Institute, 1988

25.

25. Gore

Goldberg

Spodick

, et al. A community-wide assessment of the use of pulmonary artery catheters in patients with acute myocardial infarction. Chest 1987;92:721–727

26.

Robin

ED.

Death by pulmonary artery flow-directed catheter: time for a moratorium?

Chest 1987;92:727–731

27.

27. Brun-Buisson

Doyon

Carlet

, et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: a multcenter propsective study in intensive care units. JAMA 1995;274:968–974

28.

28. Teres

Lemeshow

Avrunin

, et al. Validation of the mortality prediction model for ICU patients. Crit Care Med 1987;15:208–213

29.

Spodick

DH.

Analysis of flow directed pulmonary artery catheterization. JAMA 1989;261:1946–1947

30.

30. Iberti

Fischer

Leibowitz

, et al. A multicenter study of physicians' knowledge of the pulmonary artery catheter. JAMA 1990;264:2928–2932

31.

31. Naylor

Sibbald

Sprung

et al. Pulmonary artery catheterization. Can there be an integrated strategy for guideline development and research promotion? JAMA 1993;269:2407–2411

32.

Shoemaker

WC.

Use and abuse of the balloon tip pulmonary artery catheter: are patients getting their money's worth?

Crit Care Med 1990;18:1294–1296

Severe Sepsis Mortality in a Community Teaching. Hospital: 1983–1985 and 1989–1990

Abstract

Get full access to this article

References